TrialBreast cancer research and treatment2021

A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17).

Ippei Fukada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.